Tag: Anthony Cannavicci
MicroRNAs as promising biomarkers and therapeutic tools in hereditary hemorrhagic telangiectasia
Hereditary hemorrhagic telangiectasia (HHT) is a genetic disorder that results in potentially fatal blood vessel abnormalities. Currently, there is no cure or universally effective treatment for the condition, which remains underfunded and underdiagnosed. MicroRNAs have emerged as new biomarkers for human diseases and hold great promise for the improved diagnosis and treatment of HHT. A recent review publication by Anthony […]